Health literacy and warfarin therapy at two anticoagulation clinics in Brazil

Maria Auxiliadora Parreiras Martins; Josiane Moreira da Costa; Juliana Vaz de Melo Mambrini; Antônio Luiz Pinho Ribeiro; Emelia Benjamin; Luísa Campos Caldeira Brant; Michael K. Paasche‐Orlow; Jared W. Magnani

doi:10.1136/heartjnl-2016-310699

Abstract

1 min read

Inadequate health literacy was highly prevalent in this impoverished Brazilian cohort receiving anticoagulation with warfarin. However, we did not identify an association between health literacy and TTR. Future investigations may consider the systemic factors that contribute towards successful anticoagulation outcomes for vulnerable patient cohorts with inadequate health literacy.

Related publications

Article2003

Comparison of the Quality of Oral Anticoagulant Therapy Through Patient Self-management and Management by Specialized Anticoagulation Clinics in the Netherlands

Alain Gadisseur, W. G. M. Breukink-Engbers, F.J.M. van der Meer, A. M. H. van den Besselaar, Augueste Sturk, Frits R. Rosendaal

Archives of Internal Medicine

Article2021

Time at home among nonvalvular atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants versus warfarin

Steven Deitelzweig, Allison Keshishian, A Kang, Aaron Jenkins, Nipun Atreja, Patricia Schuler, Jenny Jiang, K Lovett, Hüseyin Yüce, Professor Gregory Lip

Article2016

Abstract 13016: Anticoagulation Control in Warfarin Treated Patients Undergoing Cardioversion for Atrial Fibrillation: A Pre-specified Ancillary Analysis From the ENSURE-AF Trial

Professor Gregory Lip, James Jin, Mingjun Sun, Michael Melino, Shannon M. Winters, Andreas Goette, Dmitry Zamoryakhin

Article2016

Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA <sub>2</sub> DS <sub>2</sub> -VASc Score 1 in Men, 2 in Women) Be Anticoagulated?

Professor Gregory Lip, Peter Brønnum Nielsen

Article2023

Impact of proton pump inhibitor on quality of anticoagulant control and outcomes in atrial fibrillation patients treated with an oral anticoagulant in the COOL-AF registry

Ply Chichareon, Professor Gregory Lip, Komsing Methavigul, Ahthit Yindeengam, Rungroj Krittayaphong